Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression.
Angiopoietin-1 and C16 Peptide Attenuate Vascular and Inflammatory Responses in Experimental Allergic Encephalomyelitis.
Axonal excitability in X-linked dominant Charcot Marie Tooth disease.
Multiple sclerosis: Worrying data on excess mortality and comorbidity in MS.
Ultrasound of inherited vs. acquired demyelinating polyneuropathies.
Biological role of Toll-like receptor-4 in the brain.
Tysabri® (natalizumab) data at ECTRIMS reaffirm positive effects of treatment for people with relapsing forms of MS
Familial Aggregation of Systemic Lupus Erythematosus and Coaggregation of Autoimmune Diseases in Affected Families.
Mitochondrial dysfunctions in 7-ketocholesterol-treated 158N oligodendrocytes without or with α-tocopherol: Impacts on the cellular profil of tricarboxylic cycle-associated organic acids, long chain saturated and unsaturated fatty acids, oxysterols, chol
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses.
Immune reconstitution and treatment response in multiple sclerosis following alemtuzumab.
Dicer and microRNA expression in multiple sclerosis and response to interferon therapy.
Demyelinating disease and psoriasis: Interferon versus dimethyl fumarate.
Quetiapine mitigates the neuroinflammation and oligodendrocyte loss in the brain of C57BL/6 mouse following cuprizone exposure for one week.
Smoking and multiple sclerosis susceptibility.
Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.
Need for differentiation of real and clinical important change in research on responsiveness of walking outcome measures in multiple sclerosis.
Different Mechanisms of Inflammation Induced in Virus and Autoimmune-Mediated Models of Multiple Sclerosis in C57BL6 Mice.
Myoinositol trends in different types of brain lesions.
Fulminant inflammatory demyelination: long-term course and magnetic resonance imaging findings.
Diagnostic value of visual evoked potentials for clinical diagnosis of multiple sclerosis.
Home or away? Choosing a setting for a falls-prevention program for people with multiple sclerosis.
Phytoestrogens mediated anti-inflammatory effect through suppression of IRF-1 and pSTAT1 expressions in lipopolysaccharide-activated microglia.
Protective effect of naringin on 3-nitropropionic acid-induced neurodegeneration through the modulation of matrix metalloproteinases and glial fibrillary acidic protein.
The signal intensity ratio of the optic nerve to ipsilateral frontal white matter is of value in the diagnosis of acute optic neuritis.
Pages
« first
‹ previous
…
638
639
640
641
642
643
644
645
646
…
next ›
last »